SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-051349
Filing Date
2019-09-25
Accepted
2019-09-25 16:20:41
Documents
1
Period of Report
2019-09-22
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K a19-18995_18k.htm 8-K 22611
  Complete submission text file 0001104659-19-051349.txt   23655
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 191114445
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences